Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
(Link esterno)

(1182 visite)

Fondo Europeo Pesca
(591 visite)

(Link esterno)

Fondazione Veronesi
(Link esterno)

(1050 visite)

(1160 visite)

(Link esterno)

(1294 visite)

(1062 visite)

(1004 visite)

MFAG Grant
(1097 visite)

(Link esterno)


Peptides targeting angiogenesis related growth factor receptors (13878 visite)

D'Andrea LD, Del Gatto A, De Rosa L, Romanelli A, Pedone C

Curr Pharm Des Current Pharmaceutical Design (ISSN: 1873-4286, 1381-6128), 2009 Jul; 15(21): 2414-2429.

Tipo di articolo: Journal Article, Research Support, Non-U. S. Gov'T, Review,

Impact factor: 4.414

Impact factor a 5 anni: 3.988

Parole chiave: Angiogenesis, Fgf, Growth Factor, Pdgf, Peptide, Vegf, Angiogenesis Inhibitor, Angiogenic Factor, Becaplermin, Bevacizumab, Fibroblast Growth Factor, Fibroblast Growth Factor 1 Antagonist, Fibroblast Growth Factor 2 Antagonist, Fibroblast Growth Factor 5 Antagonist, Fibroblast Growth Factor Receptor, Matrix Metalloproteinase, Platelet Derived Growth Factor, Platelet Derived Growth Factor Bb, Platelet Derived Growth Factor Receptor, Protein Inhibitor, Proteoheparan Sulfate, Recombinant Platelet Derived Growth Factor Bb, Unclassified Drug, Vasculotropin, Vasculotropin Receptor 1, Cell Interaction, Cell Migration, Cell Proliferation, Gene Expression Regulation, Hair Loss, Nonhuman, Priority Journal, Protein Expression, Protein Function, Protein Phosphorylation, Protein Protein Interaction, Protein Structure, Receptor Binding, Review, Structure Analysis, Animals, Intercellular Signaling Peptides And Proteins, Neovascularization, Pathologic, Platelet-Derived Growth Factor, Signal Transduction, Vascular Endothelial Growth Factor A,

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-69249113838&partnerID=40&md5=10fae5d9f0525db438ec669e564d7f35

Growth factors (GFs) are extracellular signaling polypeptides regulating cell proliferation, differentiation and survival. They exert a wide spectrum of biological activities selectively binding to and activating specific membrane receptors which then transfer the message to cell interior inducing specific biochemical pathways. GFs are especially involved in the regulation of angiogenesis, a physiological process underlining several pathologies. Molecules able to modulate angiogenesis, interfering with the molecular recognition between a GF and its receptor, have a big pharmacologic interest. Either GF and the receptor are potential drug target. Peptides are useful molecules to develop new lead compounds disrupting protein-protein interface for pharmacological applications. In this review we describe peptides targeting the receptors of the pro-angiogenic growth factors FGF, PDGF and VEGF. The biological function and the structure of each growth factor/receptor system are discussed, as well as the molecular interaction between peptides and the receptors. Finally, we highlight the pharmacological and diagnostic applications of these peptides in angiogenesis related diseases. © 2009 Bentham Science Publishers Ltd.
*** IBB - CNR ***

Dipartimento delle Scienze Biologiche, Facolta di Scienze Biotecnologiche, Universita di Napoli Federico II, via Mezzocannone 16, 80134 Napoli, Italy. ldandrea@unina.it

Istituto di Biostrutture e Bioimmagini, CNR, via Mezzocannone 16, 80134 Napoli, Italy
Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (1996) Cell, 86, pp. 353-36

Bergers, G., Benjamin, L.E., Tumorigenesis and the angiogenic switch (2003) Nat Rev Cancer, 3, pp. 401-410

Adams, R.H., Alitalo, K., Molecular regulation of angiogenesis and lymphangiogenesis (2007) Nat Rev Mol Cell Biol, 8, pp. 464-478

Carmeliet, P., Jain, R.K., Angiogenesis in cancer and other diseases (2000) Nature, 407, pp. 249-257

Folkman, J., Angiogenesis in cancer, vascular, rheumatoid and other disease (1995) Nat Med, 1, pp. 27-31

Carmeliet, P., Angiogenesis in life, disease and medicine (2005) Nature, 438, pp. 932-936

Ferrara, N., Kerbel, R.S., Angiogenesis as a therapeutic target (2005) Nature, 438, pp. 967-974

Bouis, D., Kusumanto, Y., Meijer, C., Mulder, N.H., Hospers, G.A., A review on pro- and anti-angiogenic factors as targets of clinical intervention (2006) Pharmacol Res, 53, pp. 89-103

Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., Holash, J., Vascular-specific growth factors and blood vessel formation (2000) Nature, 407, pp. 242-248

Rajkumar, T., Growth factoprs and growth factor receptors in cancer (2001) Current Science, 81, pp. 535-241

Heppeler, A., Froidevaux, S., Eberle, A.N., Maecke, H.R., Receptor targeting for tumor localisation and therapy with radiopeptides (2000) Curr Med Chem, 7, pp. 971-994

Okarvi, S.M., Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases (2004) Med Res Rev, 24, pp. 357-397

Ruegg, C., Hasmim, M., Lejeune, F.J., Alghisi, G.C., Antiangiogenic peptides and proteins: From experimental tools to clinical drugs (2006) Biochim Biophys Acta, 1765, pp. 155-177

D'Andrea, L.D., Del Gatto, A., Pedone, C., Benedetti, E., Peptide-based molecules in angiogenesis (2006) Chem Biol Drug Des, 67, pp. 115-126

Dings, R.P., Nesmelova, I., Griffioen, A.W., Mayo, K.H., Discovery and development of anti-angiogenic peptides: A structural link (2003) Angiogenesis, 6, pp. 83-91

Sulochana, K.N., Ge, R., Developing antiangiogenic peptide drugs for angiogenesis-related diseases (2007) Curr Pharm Des, 13, pp. 2074-2086

Bouma-ter Steege, J.C., Mayo, K.H., Griffioen, A.W., Angiostatic proteins and peptides (2001) Crit Rev Eukaryot Gene Expr, 11, pp. 319-334

Folkman, J., Merler, E., Abernathy, C., Williams, G., Isolation of a tumor factor responsible for angiogenesis (1971) J Exp Med, 133, pp. 275-288

Abraham, J.A., Whang, J.L., Tumolo, A., Mergia, A., Fiddes, J.C., Human basic fibroblast growth factor: Nucleotide sequence, genomic organization, and expression in mammalian cells (1986) Cold Spring Harb Symp Quant Biol, 51 (PART 1), pp. 657-668

Abraham, J.A., Mergia, A., Whang, J.L., Tumolo, A., Friedman, J., Hjerrild, K.A., Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor (1986) Science, 233, pp. 545-548

Powers, C.J., McLeskey, S.W., Wellstein, A., Fibroblast growth factors, their receptors and signaling (2000) Endocr Relat Cancer, 7, pp. 165-197

Ago, H., Kitagawa, Y., Fujishima, A., Matsuura, Y., Katsube, Y., Crystal structure of basic fibroblast growth factor at 1.6 A resolution (1991) J Biochem, 110, pp. 360-363

Eriksson, A.E., Cousens, L.S., Weaver, L.H., Matthews, B.W., Three-dimensional structure of human basic fibroblast growth factor (1991) Proc Natl Acad Sci USA, 88, pp. 3441-3445

Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G.M., Arakawa, T., Three-dimensional structures of acidic and basic fibroblast growth factors (1991) Science, 251, pp. 90-93

Zhang, J.D., Cousens, L.S., Barr, P.J., Sprang, S.R., Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta (1991) Proc Natl Acad Sci USA, 88, pp. 3446-3450

Reuss, B., von Bohlen, Halbach, O., Fibroblast growth factors and their receptors in the central nervous system (2003) Cell Tissue Res, 313, pp. 139-157

Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol 2001

2: reviews3005.1-3005.12Klagsbrun, M., Baird, A., A dual receptor system is required for basic fibroblast growth factor activity (1991) Cell, 67, pp. 229-231

Saksela, O., Moscatelli, D., Sommer, A., Rifkin, D.B., Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation (1988) J Cell Biol, 107, pp. 743-751

Turnbull, J.E., Gallagher, J.T., Heparan sulphate: Functional role as a modulator of fibroblast growth factor activity (1993) Biochem Soc Trans, 21, pp. 477-482

David, G., Integral membrane heparan sulfate proteoglycans (1993) Faseb J, 7, pp. 1023-1030

Ornitz, D.M., Leder, P., Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3 (1992) J Biol Chem, 267, pp. 16305-16311

Mansukhani, A., Dell'Era, P., Moscatelli, D., Kornbluth, S., Hanafusa, H., Basilico, C., Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin (1992) Proc Natl Acad Sci USA, 89, pp. 3305-3309

Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., Ornitz, D.M., Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor (1991) Cell, 64, pp. 841-848

Rapraeger, A.C., Krufka, A., Olwin, B.B., Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation (1991) Science, 252, pp. 1705-1708

Chaffer, C.L., Dopheide, B., Savagner, P., Thompson, E.W., Williams, E.D., Aberrant fibroblast growth factor receptor signaling in bladder and other cancers (2007) Differentiation, 75, pp. 831-842

Lee, P.L., Johnson, D.E., Cousens, L.S., Fried, V.A., Williams, L.T., Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor (1989) Science, 245, pp. 57-60

Reid, H.H., Wilks, A.F., Bernard, O., Two forms of the basic fibroblast growth factor receptor-like mRNA are expressed in the developing mouse brain (1990) Proc Natl Acad Sci USA, 87, pp. 1596-1600

Safran, A., Avivi, A., Orr-Urtereger, A., Neufeld, G., Lonai, P., Givol, D., The murine flg gene encodes a receptor for fibroblast growth factor (1990) Oncogene, 5, pp. 635-643

Dionne, C.A., Crumley, G., Bellot, F., Kaplow, J.M., Searfoss, G., Ruta, M., Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors (1990) EMBO J, 9, pp. 2685-2692

Keegan, K., Johnson, D.E., Williams, L.T., Hayman, M.J., Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 (1991) Proc Natl Acad Sci USA, 88, pp. 1095-1099

Partanen, J., Makela, T.P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern (1991) EMBO J, 10, pp. 1347-1354

Stark, K.L., McMahon, J.A., McMahon, A.P., FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse (1991) Development, 113, pp. 641-651

Zhang, X., Ibrahimi, O.A., Olsen, S.K., Umemori, H., Mohammadi, M., Ornitz, D.M., Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family (2006) J Biol Chem, 281, pp. 15694-15700

Stauber, D.J., DiGabriele, A.D., Hendrickson, W.A., Structural interactions of fibroblast growth factor receptor with its ligands (2000) Proc Natl Acad Sci USA, 97, pp. 49-54

Venkataraman, G., Shriver, Z., Davis, J.C., Sasisekharan, R., Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans (1999) Proc Natl Acad Sci USA, 96, pp. 1892-1897

Zhan, X., Plourde, C., Hu, X., Friesel, R., Maciag, T., Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin (1994) J Biol Chem, 269, pp. 20221-20224

Cross, M.J., Claesson-Welsh, L., FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition (2001) Trends Pharmacol Sci, 22, pp. 201-207

Cross, M.J., Hodgkin, M.N., Roberts, S., Landgren, E., Wakelam, M.J., Claesson-Welsh, L., Tyrosine 766 in the fibroblast growth factor receptor 1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cells (2000) J Cell Sci, 113 (PART 4), pp. 643-651

Raffioni, S., Thomas, D., Foehr, E.D., Thompson, L.M., Bradshaw, R.A., Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells (1999) Proc Natl Acad Sci USA, 96, pp. 7178-7183

Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R., Rusnati, M., Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis (2005) Cytokine Growth Factor Rev, 16, pp. 159-178

Rusnati, M., Presta, M., Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies (2007) Curr Pharm Des, 13, pp. 2025-2044

Mignatti, P., Rifkin, D.B., Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology (2000) Adv Cancer Res, 78, pp. 103-157

Stokes, C.L., Rupnick, M.A., Williams, S.K., Lauffenburger, D.A., Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor (1990) Lab Invest, 63, pp. 657-668

Terranova, V.P., DiFlorio, R., Lyall, R.M., Hic, S., Friesel, R., Maciag, T., Human endothelial cells are chemotactic to endothelial cell growth factor and heparin (1985) J Cell Biol, 101, pp. 2330-2334

Mattila, M.M., Ruohola, J.K., Valve, E.M., Tasanen, M.J., Seppanen, J.A., Harkonen, P.L., FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells (2001) Oncogene, 20, pp. 2791-2804

Gillis, P., Savla, U., Volpert, O.V., Jimenez, B., Waters, C.M., Panos, R.J., Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function (1999) J Cell Sci, 112 (PART 12), pp. 2049-2057

Klein, S., Giancotti, F.G., Presta, M., Albelda, S.M., Buck, C.A., Rifkin, D.B., Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells (1993) Mol Biol Cell, 4, pp. 973-982

Collo, G., Pepper, M.S., Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro (1999) J Cell Sci, 112 (PART 4), pp. 569-578

Sepp, N.T., Li, L.J., Lee, K.H., Brown, E.J., Caughman, S.W., Lawley, T.J., Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells (1994) J Invest Dermatol, 103, pp. 295-299

Underwood, P.A., Bean, P.A., Gamble, J.R., Rate of endothelial expansion is controlled by cell:cEll adhesion (2002) Int J Biochem Cell Biol, 34, pp. 55-69

Zhou, L., Dosanjh, A., Chen, H., Karasek, M., Divergent effects of extracellular oxygen on the growth, morphology, and function of human skin microvascular endothelial cells (2000) J Cell Physiol, 182, pp. 134-140

Gualandris, A., Rusnati, M., Belleri, M., Nelli, E.E., Bastaki, M., Molinari-Tosatti, M.P., Basic fibroblast growth factor overexpression in endothelial cells: An autocrine mechanism for angiogenesis and angioproliferative diseases (1996) Cell Growth Differ, 7, pp. 147-160

Armstrong, E., Vainikka, S., Partanen, J., Korhonen, J., Alitalo, R., Expression of fibroblast growth factor receptors in human leukemia cells (1992) Cancer Res, 52, pp. 2004-2007

Allouche, M., Bayard, F., Clamens, S., Fillola, G., Sie, P., Amalric, F., Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells (1995) Leukemia, 9, pp. 77-86

Katoh, O., Hattori, Y., Sato, T., Kimura, A., Kuramoto, A., Sugimura, T., Expression of the heparin-binding growth factor receptor genes in human megakaryocytic leukemia cells (1992) Biochem Biophys Res Commun, 183, pp. 83-92

Liuzzo, J.P., Moscatelli, D., Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: Downmodulation of FGF receptors by phorbol ester (1996) Blood, 87, pp. 245-255

Basilico, C., Moscatelli, D., The FGF family of growth factors and oncogenes (1992) Adv Cancer Res, 59, pp. 115-165

Hagedorn, M., Bikfalvi, A., Target molecules for anti-angiogenic therapy: From basic research to clinical trials (2000) Crit Rev Oncol Hematol, 34, pp. 89-110

Tille, J.C., Wood, J., Mandriota, S.J., Schnell, C., Ferrari, S., Mestan, J., Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro (2001) J Pharmacol Exp Ther, 299, pp. 1073-1085

Seghezzi, G., Patel, S., Ren, C.J., Gualandris, A., Pintucci, G., Robbins, E.S., Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis (1998) J Cell Biol, 141, pp. 1659-1673

Lindahl, U., Lidholt, K., Spillmann, D., Kjellen, L., More to "heparin" than anticoagulation (1994) Thromb Res, 75, pp. 1-32

Iozzo, R.V., San Antonio, J.D., Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena (2001) J Clin Invest, 108, pp. 349-355

Ribatti, D., Leali, D., Vacca, A., Giuliani, R., Gualandris, A., Roncali, L., In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2 (1999) J Cell Sci, 112 (PART 23), pp. 4213-4221

Presta, M., Maier, J.A., Rusnati, M., Ragnotti, G., Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form (1989) J Cell Physiol, 140, pp. 68-74

Simons, M., Horowitz, A., Syndecan-4-mediated signalling (2001) Cell Signal, 13, pp. 855-862

Rusnati, M., Urbinati, C., Presta, M., Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: Role of the low affinity heparin-like bFGF receptors (1993) J Cell Physiol, 154, pp. 152-161

Hsia, E., Richardson, T.P., Nugent, M.A., Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling (2003) J Cell Biochem, 88, pp. 1214-1225

Gajdusek, C.M., Carbon, S., Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium (1989) J Cell Physiol, 139, pp. 570-579

Gloe, T., Sohn, H.Y., Meininger, G.A., Pohl, U., Shear stress-induced release of basic fibroblast growth factor from endothelial cells is mediated by matrix interaction via integrin alpha(v)beta3 (2002) J Biol Chem, 277, pp. 23453-23458

Hartnett, M.E., Garcia, C.M., D'Amore, P.A., Release of bFGF, an endothelial cell survival factor, by osmotic shock (1999) Invest Ophthalmol Vis Sci, 40, pp. 2945-2951

Pugh, C.W., Oxygen sensing in cancer (2003) Ann Med, 35, pp. 380-390

Kuwabara, K., Ogawa, S., Matsumoto, M., Koga, S., Clauss, M., Pinsky, D.J., Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells (1995) Proc Natl Acad Sci USA, 92, pp. 4606-4610

Li, J., Shworak, N.W., Simons, M., Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites (2002) J Cell Sci, 115, pp. 1951-1959

Ornitz, D.F., heparan sulfate and FGFRs: Complex interactions essential for development (2000) Bioessays, 22, pp. 108-112

Plotnikov, A.N., Hubbard, S.R., Schlessinger, J., Mohammadi, M., Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity (2000) Cell, 101, pp. 413-424

Moy, F.J., Seddon, A.P., Bohlen, P., Powers, R., High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy (1996) Biochemistry, 35, pp. 13552-13561

Li, L.Y., Safran, M., Aviezer, D., Bohlen, P., Seddon, A.P., Yayon, A., Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis (1994) Biochemistry, 33, pp. 10999-11007

Blaber, M., DiSalvo, J., Thomas, K.A., X-ray crystal structure of human acidic fibroblast growth factor (1996) Biochemistry, 35, pp. 2086-2094

Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., Rees, D.C., Heparin structure and interactions with basic fibroblast growth factor (1996) Science, 271, pp. 1116-1120

DiGabriele, A.D., Lax, I., Chen, D.I., Svahn, C.M., Jaye, M., Schlessinger, J., Structure of a heparin-linked biologically active dimer of fibroblast growth factor (1998) Nature, 393, pp. 812-817

Plotnikov, A.N., Schlessinger, J., Hubbard, S.R., Mohammadi, M., Structural basis for FGF receptor dimerization and activation (1999) Cell, 98, pp. 641-650

Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., Leder, P., Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells (1992) Mol Cell Biol, 12, pp. 240-247

Sudhalter, J., Folkman, J., Svahn, C.M., Bergendal, K., D'Amore, P.A., Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin (1989) J Biol Chem, 264, pp. 6892-6897

Schlessinger, J., Plotnikov, A.N., Ibrahimi, O.A., Eliseenkova, A.V., Yeh, B.K., Yayon, A., Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization (2000) Mol Cell, 6, pp. 743-750

Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., Blundell, T.L., Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin (2000) Nature, 407, pp. 1029-1034

Kan, M., Wang, F., Xu, J., Crabb, J.W., Hou, J., McKeehan, W.L., An essential heparin-binding domain in the fibroblast growth factor receptor kinase (1993) Science, 259, pp. 1918-1921

Schubert, D., Ling, N., Baird, A., Multiple influences of a heparin-binding growth factor on neuronal development (1987) J Cell Biol, 104, pp. 635-643

Baird, A., Schubert, D., Ling, N., Guillemin, R., Receptor- and heparin-binding domains of basic fibroblast growth factor (1988) Proc Natl Acad Sci USA, 85, pp. 2324-2328

Ray, J., Baird, A., Gage, F.H., A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor cells (1997) Proc Natl Acad Sci USA, 94, pp. 7047-7052

Williams, E.J., Williams, G., Howell, F.V., Skaper, S.D., Walsh, F.S., Doherty, P., Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth (2001) J Biol Chem, 276, pp. 43879-43886

Ito, C., Saitoh, Y., Fujita, Y., Yamazaki, Y., Imamura, T., Oka, S., Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5 (2003) J Cell Physiol, 197, pp. 272-283

Yayon, A., Aviezer, D., Safran, M., Gross, J.L., Heldman, Y., Cabilly, S., Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library (1993) Proc Natl Acad Sci USA, 90, pp. 10643-10647

Terada, T., Mizobata, M., Kawakami, S., Yabe, Y., Yamashita, F., Hashida, M., Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells (2006) J Drug Target, 14, pp. 536-545

Maruta, F., Parker, A.L., Fisher, K.D., Hallissey, M.T., Ismail, T., Rowlands, D.C., Identification of FGF receptor-binding peptides for cancer gene therapy (2002) Cancer Gene Ther, 9, pp. 543-552

Cosic, I., Drummond, A.E., Underwood, J.R., Hearn, M.T., In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide (1994) Mol Cell Biochem, 130, pp. 1-9

McConnell, S.J., Thon, V.J., Spinella, D.G., Isolation of fibroblast growth factor receptor binding sequences using evolved phage display libraries (1999) Comb Chem High Throughput Screen, 2, pp. 155-163

Fan, H., Duan, Y., Zhou, H., Li, W., Li, F., Guo, L., Selection of peptide ligands binding to fibroblast growth factor receptor 1 (2002) IUBMB Life, 54, pp. 67-72

Oyama Jr., S., Miranda, M.T., Toma, I.N., Viviani, W., Gambarini, A.G., Mitogenic activity of peptides related to the sequence of human fibroblast growth factor-1 (1996) Biochem Mol Biol Int, 39, pp. 1237-1244

Kiyota, S., Franzoni, L., Nicastro, G., Benedetti, A., Oyama Jr., S., Viviani, W., Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants (2003) J Med Chem, 46, pp. 2325-2333

Tzeng, S.F., Deibler, G.E., DeVries, G.H., Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor (1999) Neurochem Res, 24, pp. 255-260

Li, S., Christensen, C., Kiselyov, V.V., Kohler, L.B., Bock, E., Berezin, V., Fibroblast growth factor-derived peptides: Functional agonists of the fibroblast growth factor receptor (2008) J Neurochem, 104, pp. 667-682

Anderson, A.A., Kendal, C.E., Garcia-Maya, M., Kenny, A.V., Morris-Triggs, S.A., Wu, T., A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival (2005) J Neurochem, 95, pp. 570-583

Ballinger, M.D., Shyamala, V., Forrest, L.D., Deuter-Reinhard, M., Doyle, L.V., Wang, J.X., Semirational design of a potent, artificial agonist of fibroblast growth factor receptors (1999) Nat Biotechnol, 17, pp. 1199-1204

Kiselyov, V.V., Skladchikova, G., Hinsby, A.M., Jensen, P.H., Kulahin, N., Soroka, V., Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP (2003) Structure, 11, pp. 691-701

Neiiendam, J.L., Kohler, L.B., Christensen, C., Li, S., Pedersen, M.V., Ditlevsen, D.K., An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons (2004) J Neurochem, 91, pp. 920-935

Lin, X., Takahashi, K., Campion, S.L., Liu, Y., Gustavsen, G.G., Pena, L.A., Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo (2006) Int J Mol Med, 17, pp. 833-839

Lin, X., Pena, L.A., Zamora, P.O., Campion, S.L., Takahashi, K., Augmentation of demineralized bone matrix (DBM) mineralization by a synthetic growth factor mimetic (2006) J Orthop Res, 24, pp. 2051-2058

Ross, R., Glomset, J., Kariya, B., Harker, L., A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro (1974) Proc Natl Acad Sci USA, 71, pp. 1207-1210

Kazlauskas, A., Receptor tyrosine kinases and their targets (1994) Curr Opin Genet Dev, 4, pp. 5-14

Fredriksson, L., Li, H., Eriksson, U., The PDGF family: Four gene products form five dimeric isoforms (2004) Cytokine Growth Factor Rev, 15, pp. 197-204

Heldin, C.H., Westermark, B., Mechanism of action and in vivo role of platelet-derived growth factor (1999) Physiol Rev, 79, pp. 1283-1316

Fantl, W.J., Johnson, D.E., Williams, L.T., Signalling by receptor tyrosine kinases (1993) Annu Rev Biochem, 62, pp. 453-481

Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes (1989) Science, 243, pp. 800-804

Kelly, J.D., Haldeman, B.A., Grant, F.J., Murray, M.J., Seifert, R.A., Bowen-Pope, D.F., Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation (1991) J Biol Chem, 266, pp. 8987-8992

Andrae, J., Gallini, R., Betsholtz, C., Role of platelet-derived growth factors in physiology and medicine (2008) Genes Dev, 22, pp. 1276-1312

Heldin, C.H., Eriksson, U., Ostman, A., New members of the platelet-derived growth factor family of mitogens (2002) Arch Biochem Biophys, 398, pp. 284-290

Alvarez, R.H., Kantarjian, H.M., Cortes, J.E., Biology of platelet-derived growth factor and its involvement in disease (2006) Mayo Clin Proc, 81, pp. 1241-1257

Sundberg, C., Branting, M., Gerdin, B., Rubin, K., Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells (1997) Am J Pathol, 151, pp. 479-492

Yi, E.S., Lee, H., Yin, S., Piguet, P., Sarosi, I., Kaufmann, S., Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo (1996) Am J Pathol, 149, pp. 539-548

Rutherford, C., Martin, W., Carrier, M., Anggard, E.E., Ferns, G.A., Endogenously elicited antibodies to platelet derived growth factor- BB and platelet cytosolic protein inhibit aortic lesion development in the cholesterol-fed rabbit (1997) Int J Exp Pathol, 78, pp. 21-32

Abboud, H.E., Role of platelet-derived growth factor in renal injury (1995) Annu Rev Physiol, 57, pp. 297-309

Gesualdo, L., Di Paolo, S., Milani, S., Pinzani, M., Grappone, C., Ranieri, E., Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study (1994) J Clin Invest, 94, pp. 50-58

Gesualdo, L., Pinzani, M., Floriano, J.J., Hassan, M.O., Nagy, N.U., Schena, F.P., Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis (1991) Lab Invest, 65, pp. 160-167

Yamamoto, M., Toya, Y., Jensen, R.A., Ishikawa, Y., Caveolin is an inhibitor of platelet-derived growth factor receptor signaling (1999) Exp Cell Res, 247, pp. 380-388

Engstrom, U., Engstrom, A., Ernlund, A., Westermark, B., Heldin, C.H., Identification of a peptide antagonist for platelet-derived growth factor (1992) J Biol Chem, 267, pp. 16581-16587

Brennand, D.M., Dennehy, U., Ellis, V., Scully, M.F., Tripathi, P., Kakkar, V.V., Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts (1997) FEBS Lett, 413, pp. 70-74

Brennand, D.M., Scully, M.F., Kakkar, V.V., Patel, G., A cyclic peptide analogue of loop III of PDGF-BB causes apoptosis in human fibroblasts (1997) FEBS Lett, 419, pp. 166-170

Chiara, F., Bishayee, S., Heldin, C.H., Demoulin, J.B., Autoinhibition of the platelet-derived growth factor beta-receptor tyrosine kinase by its C-terminal tail (2004) J Biol Chem, 279, pp. 19732-19738

Nagy, J.A., Dvorak, A.M., Dvorak, H.F., VEGF-A and the Induction of Pathological Angiogenesis. Annu Rev (2007) Pathol, 2, pp. 251-275

Park, J.E., Keller, G.A., Ferrara, N., The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF (1993) Mol Biol Cell, 4, pp. 1317-1326

Roth, D., Piekarek, M., Paulsson, M., Christ, H., Bloch, W., Krieg, T., Plasmin modulates vascular endothelial growth factor-Amediated angiogenesis during wound repair (2006) Am J Pathol, 168, pp. 670-684

Woolard, J., Wang, W.Y., Bevan, H.S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R.O., VEGF165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression (2004) Cancer Res, 64, pp. 7822-7835

Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., Persico, M.G., Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor (1991) Proc Natl Acad Sci USA, 88, pp. 9267-9271

Luttun, A., Tjwa, M., Carmeliet, P., Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): Novel therapeutic targets for angiogenic disorders (2002) Ann N Y Acad Sci, 979, pp. 80-93

Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels (2007) Cell, 131, pp. 463-475

Roy, H., Bhardwaj, S., Yla-Herttuala, S., Biology of vascular endothelial growth factors (2006) FEBS Lett, 580, pp. 2879-2887

Iyer, S., Acharya, K.R., Role of placenta growth factor in cardiovascular health (2002) Trends Cardiovasc Med, 12, pp. 128-134

Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions (2001) Nat Med, 7, pp. 575-583

Hauser, S., Weich, H.A., A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta (1993) Growth Factors, 9, pp. 259-268

Ferrara, N., Gerber, H.P., LeCouter, J., The biology of VEGF and its receptors (2003) Nat Med, 9, pp. 669-676

Ferrara N. VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol 2000

11: 617-24Ferrara, N., Davis-Smyth, T., The biology of vascular endothelial growth factor (1997) Endocr Rev, 18, pp. 4-25

Cross, M.J., Dixelius, J., Matsumoto, T., Claesson-Welsh, L., VEGF-receptor signal transduction (2003) Trends Biochem Sci, 28, pp. 488-494

Veikkola, T., Karkkainen, M., Claesson-Welsh, L., Alitalo, K., Regulation of angiogenesis via vascular endothelial growth factor receptors (2000) Cancer Res, 60, pp. 203-212

Hicklin, D.J., Ellis, L.M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis (2005) J Clin Oncol, 23, pp. 1011-1027

Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., Shibuya, M., Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice (1998) Proc Natl Acad Sci USA, 95, pp. 9349-9354

Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment (2002) Nat Med, 8, pp. 841-849

Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 (2003) Nat Med, 9, pp. 936-943

Kendall, R.L., Thomas, K.A., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor (1993) Proc Natl Acad Sci USA, 90, pp. 10705-10709

Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia (2003) J Clin Invest, 111, pp. 649-658

Oliver, G., Alitalo, K., The lymphatic vasculature: Recent progress and paradigms (2005) Annu Rev Cell Dev Biol, 21, pp. 457-483

Alitalo, K., Tammela, T., Petrova, T.V., Lymphangiogenesis in development and human disease (2005) Nature, 438, pp. 946-953

Achen, M.G., Williams, R.A., Minekus, M.P., Thornton, G.E., Stenvers, K., Rogers, P.A., Localization of vascular endothelial growth factor D in malignant melanoma suggests a role in tumour angiogenesis (2001) J Pathol, 193, pp. 147-154

Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer (1999) Am J Pathol, 154, pp. 1381-1390

Pellet-Many, C., Frankel, P., Jia, H., Zachary, I., Neuropilins: Structure, function and role in disease (2008) Biochem J, 411, pp. 211-226

Geretti, E., Shimizu, A., Klagsbrun, M., Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis (2008) Angiogenesis, 11, pp. 31-39

Muller, Y.A., Christinger, H.W., Keyt, B.A., de Vos, A.M., The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: Multiple copy flexibility and receptor binding (1997) Structure, 5, pp. 1325-1338

Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C., de Vos, A.M., Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site (1997) Proc Natl Acad Sci USA, 94, pp. 7192-7197

Pan, B., Li, B., Russell, S.J., Tom, J.Y., Cochran, A.G., Fairbrother, W.J., Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor (2002) J Mol Biol, 316, pp. 769-787

Wiesmann, C., Christinger, H.W., Cochran, A.G., Cunningham, B.C., Fairbrother, W.J., Keenan, C.J., Crystal structure of the complex between VEGF and a receptor-blocking peptide (1998) Biochemistry, 37, pp. 17765-17772

Muller, Y.A., Chen, Y., Christinger, H.W., Li, B., Cunningham, B.C., Lowman, H.B., VEGF and the Fab fragment of a humanized neutralizing antibody: Crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface (1998) Structure, 6, pp. 1153-1167

Starovasnik, M.A., Christinger, H.W., Wiesmann, C., Champe, M.A., de Vos, A.M., Skelton, N.J., Solution structure of the VEGF-binding domain of Flt-1: Comparison of its free and bound states (1999) J Mol Biol, 293, pp. 531-544

Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., de Vos, A.M., Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor (1997) Cell, 91, pp. 695-704

Christinger, H.W., Fuh, G., de Vos, A.M., Wiesmann, C., The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 (2004) J Biol Chem, 279, pp. 10382-10388

McTigue, M.A., Wickersham, J.A., Pinko, C., Showalter, R.E., Parast, C.V., Tempczyk-Russell, A., Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: A key enzyme in angiogenesis (1999) Structure, 7, pp. 319-330

Ruch, C., Skiniotis, G., Steinmetz, M.O., Walz, T., Ballmer-Hofer, K., Structure of a VEGF-VEGF receptor complex determined by electron microscopy (2007) Nat Struct Mol Biol, 14, pp. 249-250

Keyt, B.A., Nguyen, H.V., Berleau, L.T., Duarte, C.M., Park, J., Chen, H., Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis (1996) J Biol Chem, 271, pp. 5638-5646

Lee, C.C., Kreusch, A., McMullan, D., Ng, K., Spraggon, G., Crystal structure of the human neuropilin-1 b1 domain (2003) Structure, 11, pp. 99-108

Appleton, B.A., Wu, P., Maloney, J., Yin, J., Liang, W.C., Stawicki, S., Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding (2007) Embo J, 26, pp. 4902-4912

Vander Kooi, C.W., Jusino, M.A., Perman, B., Neau, D.B., Bellamy, H.D., Leahy, D.J., Structural basis for ligand and heparin binding to neuropilin B domains (2007) Proc Natl Acad Sci USA, 104, pp. 6152-6157

Zachary, I., Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules (2003) IDrugs, 6, pp. 224-231

Ferrara, N., Hillan, K.J., Gerber, H.P., Novotny, W., Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer (2004) Nat Rev Drug Discov, 3, pp. 391-400

Underiner, T.L., Ruggeri, B., Gingrich, D.E., Development of vascular endothelial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy (2004) Curr Med Chem, 11, pp. 731-745

Sun, J., Blaskovich, M.A., Jain, R.K., Delarue, F., Paris, D., Brem, S., Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor (2004) Cancer Res, 64, pp. 3586-3592

Holash, J., Davis, S., Papadopoulos, N., Croll, S.D., Ho, L., Russell, M., VEGF-Trap: A VEGF blocker with potent antitumor effects (2002) Proc Natl Acad Sci USA, 99, pp. 11393-11398

Niethammer, A.G., Xiang, R., Becker, J.C., Wodrich, H., Pertl, U., Karsten, G., A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth (2002) Nat Med, 8, pp. 1369-1375

Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., Muramatsu, T., A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics (2004) Cancer Res, 64, pp. 3365-3370

Quesada, A.R., Munoz-Chapuli, R., Medina, M.A., Anti-angiogenic drugs: From bench to clinical trials (2006) Med Res Rev, 26, pp. 483-530

Jia, H., Jezequel, S., Lohr, M., Shaikh, S., Davis, D., Soker, S., Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF (2001) Biochem Biophys Res Commun, 283, pp. 164-173

Bainbridge, J.W., Jia, H., Bagherzadeh, A., Selwood, D., Ali, R.R., Zachary, I., A peptide encoded by exon 6 of VEGF (EG3306) inhibits VEGF-induced angiogenesis in vitro and ischaemic retinal neovascularisation in vivo (2003) Biochem Biophys Res Commun, 302, pp. 793-799

Cheng, L., Jia, H., Lohr, M., Bagherzadeh, A., Holmes, D.I., Selwood, D., Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production (2004) J Biol Chem, 279, pp. 30654-30661

Giordano, R.J., Cardo-Vila, M., Lahdenranta, J., Pasqualini, R., Arap, W., Biopanning and rapid analysis of selective interactive ligands (2001) Nat Med, 7, pp. 1249-1253

Giordano, R.J., Anobom, C.D., Cardo-Vila, M., Kalil, J., Valente, A.P., Pasqualini, R., Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors (2005) Chem Biol, 12, pp. 1075-1083

Binetruy-Tournaire, R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis (2000) Embo J, 19, pp. 1525-1533

Perret, G.Y., Starzec, A., Hauet, N., Vergote, J., Le Pecheur, M., Vassy, R., In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 (2004) Nucl Med Biol, 31, pp. 575-581

Starzec, A., Vassy, R., Martin, A., Lecouvey, M., Di Benedetto, M., Crepin, M., Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 (2006) Life Sci, 79, pp. 2370-2381

Starzec, A., Ladam, P., Vassy, R., Badache, S., Bouchemal, N., Navaza, A., Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex (2007) Peptides, 28, pp. 2397-2402

Bae, D.G., Kim, T.D., Li, G., Yoon, W.H., Chae, C.B., Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis (2005) Clin Cancer Res, 11, pp. 2651-2661

von Wronski, M.A., Raju, N., Pillai, R., Bogdan, N.J., Marinelli, E.R., Nanjappan, P., Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor (2006) J Biol Chem, 281, pp. 5702-5710

Qin, X., Wan, Y., Li, M., Xue, X., Wu, S., Zhang, C., Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy (2007) J Biochem, 142, pp. 79-85

Shrivastava, A., von Wronski, M.A., Sato, A.K., Dransfield, D.T., Sexton, D., Bogdan, N., A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases (2005) Protein Eng Des Sel, 18, pp. 417-424

Goncalves, V., Gautier, B., Coric, P., Bouaziz, S., Lenoir, C., Garbay, C., Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor (2007) J Med Chem, 50, pp. 5135-5146

Taylor, A.P., Goldenberg, D.M., Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts (2007) Mol Cancer Ther, 6, pp. 524-531

Udugamasooriya, D.G., Dineen, S.P., Brekken, R.A., Kodadek, T., A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity (2008) J Am Chem Soc, 130, pp. 5744-5752

Albini, A., Soldi, R., Giunciuglio, D., Giraudo, E., Benelli, R., Primo, L., The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells (1996) Nat Med, 2, pp. 1371-1375

D'Andrea, L.D., Iaccarino, G., Fattorusso, R., Sorriento, D., Carannante, C., Capasso, D., Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (2005) Proc Natl Acad Sci USA, 102, pp. 14215-14220

Dudar, G.K., D'Andrea, L.D., Di Stasi, R., Pedone, C., Wallace, J.L., A Vascular Endothelial Growth Factor Mimetic Accelerates Gastric Ulcer Healing in an iNOS-Dependent Manner (2008) Am J Physiol, , Gastrointest Liver Physiol

Waslif, J., (2004) Angiogenesis Inhibitors and Stimulators:tHe Emergence of a New Market

Jacobs, J., Combating cardiovascular disease with angiogenic therapy (2007) Drug Discov Today, 12, pp. 1040-1045

Kerbel, R., Folkman, J., Clinical translation of angiogenesis inhibitors (2002) Nat Rev Cancer, 2, pp. 727-739

Featherstone, J., Griffiths, S., From the analyst's couch. Drugs that target angiogenesis (2002) Nat Rev Drug Discov, 1, pp. 413-414

Cristofanilli, M., Charnsangavej, C., Hortobagyi, G.N., Angiogenesis modulation in cancer research: Novel clinical approaches (2002) Nat Rev Drug Discov, 1, pp. 415-426

Ferrara, N., Alitalo, K., Clinical applications of angiogenic growth factors and their inhibitors (1999) Nat Med, 5, pp. 1359-1364

Choe, Y.S., Lee, K.H., Targeted in vivo imaging of angiogenesis: Present status and perspectives (2007) Curr Pharm Des, 13, pp. 17-31

Ferrara, N., Mass, R.D., Campa, C., Kim, R., Targeting VEGF-A to treat cancer and age-related macular degeneration (2007) Annu Rev Med, 58, pp. 491-504

Million, R.P., Therapeutic area crossroads:aNti-angiogenesis (2008) Nature Rev. Drug Discov, 7, pp. 115-116

Simons, M., Ware, J.A., Therapeutic angiogenesis in cardiovascular disease (2003) Nat Rev Drug Discov, 2, pp. 863-871

Weis, S.M., Cheresh, D.A., Pathophysiological consequences of VEGF-induced vascular permeability (2005) Nature, 437, pp. 497-504

Lee, C.G., Link, H., Baluk, P., Homer, R.J., Chapoval, S., Bhandari, V., Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung (2004) Nat Med, 10, pp. 1095-1103

Molin, D., Post, M.J., Therapeutic angiogenesis in the heart: Protect and serve (2007) Curr Opin Pharmacol, 7, pp. 158-163

Emanueli, C., Madeddu, P., Changing the logic of therapeutic angiogenesis for ischemic disease (2005) Trends Mol Med, 11, pp. 207-216

Hetian, L., Ping, A., Shumei, S., Xiaoying, L., Luowen, H., Jian, W., A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor (2002) J Biol Chem, 277, pp. 43137-43142

Zilberberg, L., Shinkaruk, S., Lequin, O., Rousseau, B., Hagedorn, M., Costa, F., Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor (2003) J Biol Chem, 278, pp. 35564-35573

El-Mousawi, M., Tchistiakova, L., Yurchenko, L., Pietrzynski, G., Moreno, M., Stanimirovic, D., A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library (2003) J Biol Chem, 278, pp. 46681-46691

An, P., Lei, H., Zhang, J., Song, S., He, L., Jin, G., Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library (2004) Int J Cancer, 111, pp. 165-173

Contiene: [X]      Estesa         Autori: [X]      Tipo di lavoro: [X]
Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
[Pulisci modulo]
Pietropaolo A, Magri A, Greco V, Losasso V, La Mendola D, Sciuto S, Carloni P, Rizzarelli E
* Binding of Zn(II) to Tropomyosin Receptor Kinase A in Complex with Its Cognate Nerve Growth Factor: Insights from Molecular Simulation and in Vitro Essays (54 visite)
Acs Chem Neurosci (ISSN: 1948-7193electronic, 1948-7193linking), 2018 Jan 12; N/D: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Petrillo S, Chiabrando D, Genova T, Fiorito V, Ingoglia G, Vinchi F, Mussano F, Carossa S, Silengo L, Altruda F, Merlo GR, Munaron L, Tolosano E
* Heme accumulation in endothelial cells impairs angiogenesis by triggering paraptosis (40 visite)
Cell Death Differ (ISSN: 1476-5403electronic, 1350-9047linking), 2017 Dec 11; N/D: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zimbone S, Monaco I, Giani F, Pandini G, Copani AG, Giuffrida ML, Rizzarelli E
* Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells (284 visite) (PDF 92 visite)
Aging Cell (ISSN: 1474-9726electronic, 1474-9718linking), 2017 Nov 01; N/D: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Crich SG, Terreno E, Aime S
* Nano-sized and other improved reporters for magnetic resonance imaging of angiogenesis (46 visite)
Adv Drug Deliv Rev (ISSN: 1872-8294electronic, 0169-409xlinking), 2017 Sep 15; 119: 61-72.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanza V, Travaglia A, Malgieri G, Fattorusso R, GrassoG, Di Natale G, Zito V, Arena G, Milardi D, Rizzarelli E
* Ubiquitin Associates with the N-Terminal Domain of Nerve Growth Factor: The Role of Copper(II) Ions (87 visite) (PDF 75 visite)
Chemistry (ISSN: 1521-3765electronic, 0947-6539linking), 2016 Dec 05; 22(49): 17767-17775.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bogdanovich S, Kim Y, Mizutani T, Yasuma R, Tudisco L, Cicatiello V, Bastos-carvalho A, Kerur N, Hirano Y, Baffi JZ, Tarallo V, Li S, Yasuma T, Arpitha P, Fowler BJ, Wright CB, Apicella I, Greco A, Brunetti A, Ruvo M, Sandomenico A, Nozaki M, Ijima R, Kaneko H, Ogura Y, Terasaki H, Ambati BK, Leusen JH, Langdon WY, Clark MR, Armour KL, Bruhns P, Verbeek JS, Gelfand BD, De Falco S, Ambati J
* Human IgG1 antibodies suppress angiogenesis in a target-independent manner (259 visite)
Signal Transduct Target Ther (ISSN: 2059-3635print), 2016; 1: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, De Rosa L, Romanelli A, D'Andrea LD
* Peptides Interacting with Growth Factor Receptors Regulating Angiogenesis (79 visite)
Frontiers In Medicinal Chemistry, 2016; 9: 130-160.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Miceli M, Dell'Aversana C, Russo R, Rega C, Cupelli L, Ruvo M, Altucci L, Chambery A
* Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells (91 visite)
Proteomics (ISSN: 1615-9853), 2016; 16(4): 674-688.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Giuffrida ML, Tomasello MF, Pandini G, Caraci F, Battaglia G, Busceti C, Di Pietro P, Pappalardo G, Attanasio F, Chiechio S, Bagnoli S, Nacmias B, Sorbi S, Vigneri R, Rizzarelli E, Nicoletti F, Copani A
* Monomeric ss-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons (169 visite)
Frontiers In Cellular Neuroscience (ISSN: 1662-5102electronic, 1662-5102linking), 2015 Aug 7; 9(AUGUST): 297-297.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (116 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Carriero MV, Bifulco K, Minopoli M, Lista L, Maglio O, Mele L, Di Carluccio G, De Rosa M, Pavone V
* UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency (131 visite)
Mol Cancer Ther Molecular Cancer Therapeutics (ISSN: 1538-8514electronic, 1535-7163linking), 2014 May; 13(5): 1092-1104.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF
* IL-32 Promotes Angiogenesis (191 visite)
Journal Of Immunology (ISSN: 0022-1767), 2014 Jan 15; 192(2): 589-602.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Formisano L, Nappi L, Rosa R, Marciano R, D'Amato C, D'Amato V, Damiano V, Raimondo L, Iommelli F, Scorziello A, Troncone G, Veneziani BM, Parsons SJ, De Placido S, Bianco R
* Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models (136 visite)
Breast Cancer Res Biomed Central Ltd (ISSN: 1465-5411), 2014; 16(3): R45-R45.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Severino V, Alessio N, Farina A, Sandomenico A, Cipollaro M, Peluso G, Galderisi U, Chambery A
* Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells (152 visite)
Cell Death Dis (ISSN: 2041-4889, 2041-4889electronic), 2013 Nov 7; 4(11): e911-e911.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Mancini M, Greco A, Salvatore G, Liuzzi R, Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A, Salvatore M
* Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice (231 visite)
Bmc Medical Imaging (ISSN: 1471-2342), 2013 Sep 12; 13: 31-31.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, Satriano C, Giuffrida ML, La Mendola D, Rampazzo E, Prodi L, Rizzarelli E
* Electrostatically driven interaction of silica-supported lipid bilayer nanoplatforms and a nerve growth factor-mimicking peptide (104 visite)
Soft Matter (ISSN: 1744-683x), 2013; 9(18): 4648-4654.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Galasso G, De Rosa R, Ciccarelli M, Sorriento D, Del Giudice C, Strisciuglio T, De Biase C, Luciano R, Piccolo R, Pierri A, Di Gioia G, Prevete N, Trimarco B, Piscione F, Iaccarino G
* β2-adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis (98 visite)
Circ Res (ISSN: 0009-7330, 1524-4571electronic, 0009-7330linking), 2013; 112(7): 1026-1034.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Finetti F, Basile A, Capasso D, Di Gaetano S, Di Stasi R, Pascale M, Turco CM, Ziche M, Morbidelli L, D'Andrea LD
* Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis (156 visite)
Biochem Pharmacol Biochemical Pharmacology (ISSN: 0006-2952, 1873-2968), 2012 Sep 1; 84(3): 303-311.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ziaco B, Diana D, Capasso D, Palumbo R, Celentano V, Di Stasi R, Fattorusso R, D'Andrea LD
* C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties (122 visite)
Biochem Biophys Res Commun Biochemical And Biophysical Research Communications (ISSN: 0006-291x), 2012 Jul 27; 424(2): 290-294.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer (219 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
* 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer (156 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cirillo G, Colangelo AM, Bianco MR, Cavaliere C, Zaccaro L, Sarmientos P, Alberghina L, Papa M
* BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury (102 visite)
Biotechnology Advances (ISSN: 0734-9750), 2012 Jan; 30(1): 223-232.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Basile A, De Rosa L, Di Stasi R, Auriemma S, Arra C, Pedone C, Turco MC, Fattorusso R, D'Andrea LD
* Beta-Hairpin Peptide That Targets Vascular Endothelial Growth Factor (vegf) Receptors: Design, Nmr Characterization, And Biological Activity (153 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 1083-351x, 0021-9258), 2011 Dec 2; 286(48): 41680-41691.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Gasperi M, Prinster A, Vacca G, Pivonello C, Orefice G, Colao A, Morra VB
* Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients (112 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2011 Dec; 18(12): 1402-1406.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Travaglia A, Arena G, Fattorusso R, Isernia C, La Mendola D, Malgieri G, Nicoletti VG, Rizzarelli E
* The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor (116 visite)
Chemistry (ISSN: 1521-3765, 0947-6539, 1521-3765electronic), 2011 Mar 21; 17(13): 3726-3738.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Basile A, Del Gatto A, Diana D, Di Stasi R, Falco A, Festa M, Rosati A, Barbieri A, Franco R, Arra C, Pedone C, Fattorusso R, Turco MC, D'Andrea LD
* Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo (122 visite)
J Med Chem (ISSN: 1520-4804, 0022-2623, 0022-2623print), 2011 Mar 10; 54(5): 1391-1400.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cirillo G, Bianco MR, Colangelo AM, Cavaliere C, Daniele DL, Zaccaro L, Alberghina L, Papa M
* Reactive astrocytosis-induced perturbation of synaptic homeostasis is restored by nerve growth factor (116 visite)
Neurobiology Of Disease (ISSN: 0969-9961), 2011 Mar; 41(3): 630-639.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ciccarelli M, Sorriento D, Cipolletta E, Santulli G, Fusco A, Zhou R-H, Eckhart AD, Peppel K, Koch WJ, Trimarco B, Iaccarino G
* Impaired neoangiogenesis in β2-adrenoceptor gene-deficient mice: Restoration by intravascular human β2-adrenoceptor gene transfer and role of NFkB and CREB transcription factors (103 visite)
Br J Pharmacol British Journal Of Pharmacology (ISSN: 0007-1188), 2011; 162(3): 712-721.
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Romanelli A, Di Stasi R, Pedone C
* Bioinorganic aspects of angiogenesis (112 visite)
Dalton Trans (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Sep 7; 39(33): 7625-7636.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N
* Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist (91 visite)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jun 10; 53(11): 4428-4440.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Alberobello AT, D'Esposito V, Marasco D, Doti N, Ruvo M, Bianco R, Tortora G, Esposito I, Fiory F, Miele C, Beguinot F, Formisano P
* Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell Death (101 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2010 Feb 26; 285(9): 6563-6572.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma MC, Quarantelli M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao AM, Morra VB
* Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients (80 visite)
Journal Of The Neurological Sciences (ISSN: 0022-510x), 2009 Oct; 285: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lanzillo R, Di Somma C, Quarantelli M, Gasperi M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao A, Morra VB
* Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis (122 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Sep; 15(9): 1402-1406.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Cittadini A, Monti MG, Castiello MC, D'Arco E, Galasso G, Sorriento D, Saldamarco L, De Paulis A, Napoli R, Iaccarino G, Saccà L
* Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury (104 visite)
J Thromb Haemost Journal Of Thrombosis And Haemostasis (ISSN: 1538-7933), 2009; 7(11): 1920-1928.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ponticelli S, Marasco D, Tarallo V, Albuquerque RJC, Mitola S, Takeda A, Stassen J, Presta M, Ambati J, Ruvo M, De Falco S
* Modulation of Angiogenesis by a Tetrameric Tripeptide That Antagonizes Vascular Endothelial Growth Factor Receptor (109 visite)
J Biol Chem Journal Of Biological Chemistry (ISSN: 0021-9258, 1083-351x), 2008 Dec 5; 283(49): 34250-34259.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL
* A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner (139 visite)
Am J Physiol Gastrointest Liver Physiol American Journal Of Physiology Gastrointestinal And Liver Physiology (ISSN: 0193-1857), 2008 Sep; 295(2): G374-G374.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Ponticelli S, Takeda A, Mitola S, Stassen J, Presta M, Ambati J, Ruvo M, De Falco S, Marasco D
* Angiogenesis modulation: identification of tetrameric tripeptide as inhibitor of VEGFR-1 by the screening of peptide combinatiorial libraries (105 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Di Stasi R, Capasso D, Diana D, Fattorusso R, Pedone C, D'Andrea LD
* Vascular Endothelial Growth Factor (VEGF) and its receptors: key regulators of angiogenesis (90 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Romano S, Mallardo M, Chiurazzi F, Bisogni R, D'Angelillo A, Liuzzi R, Compare G, Romano MF
* The effect of FK506 on transforming growth factor beta signaling and apaptosis in chronic lymphocytic leukemia B cells (95 visite)
Haematologica (ISSN: 0390-6078, 0006-4971, 0006-6497), 2008 Jul; 93(7): 1039-1048.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colangelo AM, Bianco MR, Vitagliano L, Cavaliere C, Cirillo G, De Gioia L, Diana D, Colombo D, Redaelli C, Zaccaro L, Morelli G, Papa M, Sarmientos P, Alberghina L, Martegani E
* A New Nerve Growth Factor (ngf)-Mimetic Peptide Active On Neuropathic Pain In Rats (139 visite)
Journal Of Neuroscience (ISSN: 0270-6474, 0270-0647), 2008 Mar 12; 28(11): 2698-2709.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Migliore T, Parrella LS, Caputi A, Silvestri N, Romano R, Pace L, Imbriaco M, Losi MA, Betocchi S
* Pathogenesis of hypertrophic cardiomyopathy. Impact of growth factors on left ventricular anatomy (103 visite)
Minerva Cardioangiol (ISSN: 0026-4725), 2008 Feb; 56(1): 13-20.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Diana D, Ziaco B, Colombo G, Scarabelli G, Romanelli A, Fedone C, Fattorusso R, D'Andrea LD
* Structural determinants of the unusual helix stability of a de novo engineered vascular endothelial growth factor (VEGF) mimicking peptide (118 visite)
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2008; 14(14): 4164-4166.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bianco MR, Cirillo G, Cavaliere C, Colangelo AM, Vitagliano L, Morelli G, Sarmientos P, Martegani E, Alberghina L, Papa M
* A new Nerve Growth Factor (NGF)-mimetic peptide reduces gliosis and is active on neuropathic pain in rats (110 visite)
Neuron Glia Biology (ISSN: 1740-925x), 2007; 2: N/D-N/D.
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Del Gatto A, Pedone C, Benedetti E
* Peptide-based molecules in angiogenesis (146 visite)
Chem Biol Drug Des Chemical Biology And Drug Design (ISSN: 1747-0277, 1747-0285), 2006 Feb; 67(2): 115-126.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Del Gatto A, D'Andrea LD, Zaccaro L, Saviano M, Pedone C, Benedetti E
* Engineering Peptides In Angiogenesis (116 visite)
Biopolymers, 2006; 0: 215-216.
Dettagli    Esporta in BibTeX    Esporta in EndNote

D'Andrea LD, Iaccarino G, Fattorusso R, Sorriento D, Carannante C, Capasso D, Trimarco B, Pedone C
* Targeting angiogenesis: Structural characterization and biological properties of a de novo engineered VEGF mimicking peptide (141 visite)
Proc Natl Acad Sci U S A (ISSN: 0027-8424, 1091-6490, 0027-8424print), 2005 Oct 4; 102(40): 14215-14220.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G, Cipolletta E, Cerullo V, Cimini V, Altobelli GG, Piscione F, Priante O, Pastore L, Chiariello M, Salvatore F, Koch WJ, Trimarco B
* Ischemic neoangiogenesis enhanced by β2-adrenergic receptor overexpression: A novel role for the endothelial adrenergic system (107 visite)
Circ Res (ISSN: 0009-7330, 1524-4571electronic), 2005; 97(11): 1182-1189.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Morte A, Pivonello R, Salvatore M, Lombardi G
* Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance (89 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2001 Apr; 86(4): 1551-1557.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Lombardi G, Colao A, Cuocolo A, Longobardi S, Di Somma C, Orio F, Merola B, Nicolai E, Salvatore M
Cardiological aspects of growth hormone and insulin-like growth factor- (88 visite)
J Pediatr Endocrinol Metab (ISSN: 0334-018x), 1997 Nov; 10(6): 553-560.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Caraglia M, Tagliaferri P, Correale P, Genua G, Pinto A, Del Vecchio S, Esposito G, Bianco AR
Cancer Immunology Immunotherapy (ISSN: 0340-7004), 1993 Sep; 37(3): 150-156.
Dettagli    Esporta in BibTeX    Esporta in EndNote

Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, Persico MG
Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14 (117 visite)
Oncogene (ISSN: 0950-9232, 1476-5594), 1993; 8(4): 925-931.
Dettagli    Esporta in BibTeX    Esporta in EndNote

51 Records (45 escludendo Abstract e Conferenze).
Impact factor totale: 231.692 (213.612 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 234.716 (218.803 escludendo Abstract e Conferenze).

    Esporta in BibTeX    Esporta in EndNote

Ultima modifica di Marco Comerci in data Thursday 19 March 2015, 12:45:16
13878 visite. Ultima visita in data Thursday 15 November 2018, 10:15:19

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Thursday 15 November 2018, 17:18:12